1. Home /
  2. Biotechnology

Biotechnology

Intuitive Surgical Gets New Price Targets After Earnings Beat

Intuitive Surgical Gets New Price Targets After Earnings Beat

The surgical equipment manufacturer's second quarter report surprised analysts, setting Intuitive up for a strong second half.

Prepare for Volatility Around Biogen Ahead of Alzheimer's Presentation: Leerink

Prepare for Volatility Around Biogen Ahead of Alzheimer's Presentation: Leerink

Positive readings from the biotech giant's Alzheimer's drug could drive the stock to as high as $393.

5 Big Biotech Stories to Watch

5 Big Biotech Stories to Watch

The biotech and pharmaceutical industries have had some big news in recent weeks. Here's what you should know to stay up-to-date.

3 'Strong Buy' Healthcare Stocks Poised to Surge

3 'Strong Buy' Healthcare Stocks Poised to Surge

Here are the top healthcare bets ticking all the boxes for analysts.

Indivior Soars on Court Ruling Blocking Sales of Rival's Generic Opioid Drug

Indivior Soars on Court Ruling Blocking Sales of Rival's Generic Opioid Drug

The drug company received a preliminary injunction blocking Dr. Reddy's Laboratories from selling its opioid treatment drug.

OncoCyte Surges on 'Encouraging' Results for Diagnostic Test for Cancer

OncoCyte Surges on 'Encouraging' Results for Diagnostic Test for Cancer

The company sees the market for lung cancer detection as being worth $4.7 billion annually.

Market Madness: Twitter Slumps and Biotech is Going for an M&A Record

Market Madness: Twitter Slumps and Biotech is Going for an M&A Record

Let's review what happened on Monday.

Axovant, Benetic Jump on Agreement to Develop Gene Therapy for MD

Axovant, Benetic Jump on Agreement to Develop Gene Therapy for MD

The deal is part of Axovant's strategy to focus on neurological gene therapies.

Biogen Sparks Hope on Treating Alzheimer's Disease: Everything You Must Know

Biogen Sparks Hope on Treating Alzheimer's Disease: Everything You Must Know

Biogen delivered promising results on a new Alzheimer's disease treatment. And investors rewarded the company accordingly.

Biogen Shares Soar on Positive Alzheimer's Drug Results

Biogen Shares Soar on Positive Alzheimer's Drug Results

The company's drug showed promising results versus a placebo in a Phase 2 trial.